Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Johnson & Johnson (NY:JNJ)

174.53 +0.11 (+0.06%)
Streaming Delayed Price Updated: 11:41 AM EDT, Aug 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,602,298
Open 174.31
Bid (Size) 174.53 (2)
Ask (Size) 174.56 (2)
Prev. Close 174.42
Today's Range 172.72 - 174.66
52wk Range 140.68 - 174.75
Shares Outstanding 2,628,679,824
Dividend Yield 2.98%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Palantir Is Now the 19th Largest Public Company. Is This House of Cards About to Come Crashing Down?
Palantir Technologies is priced for perfection. Unfortunately, no situation on Wall Street is ever perfect. 
Via The Motley Fool
Topics Artificial Intelligence
Fed Watch: September Rate Cut Now 96% Likely After Favorable Inflation Data
The financial markets are abuzz with heightened expectations for a Federal Reserve interest rate cut in September, with probabilities soaring to an overwhelming 96%. This dramatic shift in sentiment... 
Via MarketMinute
Topics Bonds Credit Cards Economy

Performance

YTD
+21.2%
+21.2%
1 Month
+11.3%
+11.3%
3 Month
+19.2%
+19.2%
6 Month
+12.4%
+12.4%
1 Year
+10.2%
+10.2%

More News

Read More
Vor Bio Rallies On Strong Data For Autoimmune Drug Candidate
Via Benzinga
If You're In Your 20's, Consider Buying These 3 Healthcare Stocks
Via The Motley Fool
Topics Retirement
Johnson & Johnson EVP Sells JNJ Shares Worth $3 Million
Via The Motley Fool
Topics Regulatory Compliance
Got $1,000? 3 Dividend Stocks to Buy and Hold Forever
Via The Motley Fool
The Specter of Stagflation: Trump's Tariffs Cast a Long Shadow Over the U.S. Economy
Via MarketMinute
Topics Economy Government Supply Chain
Novartis' Investigational Drug Aces Two Pivotal Trials For Chronic Disease Impacting Tears, Saliva
Via Benzinga
3 Big Dividend Plays With Strong Earnings to Back Them
Via MarketBeat
Topics Earnings
Worried About a Fading Rally? Consider These 3 Dividend Stocks
Via MarketBeat
Topics Artificial Intelligence Economy
5 Dividend Stocks to Hold for the Next 5 Years
Via The Motley Fool
3 Stocks Retirees Should Absolutely Love
Via The Motley Fool
Topics Economy Retirement
Is the Vanguard Value ETF the Simplest Way to Consistently Collect More Passive Income Than the S&P 500?
Via The Motley Fool
Topics ETFs Regulatory Compliance Stocks
Genmab/AbbVie Partnered Blood Cancer Combination Drug Cuts Risk Of Disease Progression By 79%
Via Benzinga
U.S. Labor Market Shows Mixed Signals: Unemployment Claims Tick Up, Job Growth Slows
Via MarketMinute
Topics Bonds Economy
Political Tremors Rattle Markets: The Profound Impact of U.S. Elections and Tariff Shocks
Via MarketMinute
Topics Economy Government Stocks
U.S. Economy Navigates Choppy Waters: Weak Payrolls, Labor Slowdown, and Persistent Inflation Reshape Market Outlook
Via MarketMinute
Topics Earnings Economy World Trade
Stagflation Fears Resurface: Economic Data Signals Market Caution
Via MarketMinute
Topics Bonds Economy Government
Stagflation Specter Haunts Markets as Economic Data Disappoints
Via MarketMinute
Topics Economy Stocks World Trade
RFK Jr. Sued By Eli Lilly, Amgen Over Drug Discount Program
Via Benzinga
Topics Lawsuit
Wall Street Giants Warn of Impending Stock Market Pullback: Is a Correction on the Horizon?
Via MarketMinute
Topics Artificial Intelligence Economy World Trade
Beyond Jobs: Key Economic Indicators Investors Are Watching for Market Health Clues
Via MarketMinute
Topics Economy Supply Chain World Trade
Are Stocks Overheating? Analysts Debate Market Valuations Amidst Record Highs
Via MarketMinute
Topics Bonds Economy
Johnson & Johnson (NYSE:JNJ) Stands Out as a Top Dividend Stock for Reliable Income Investors
Via Chartmill
Pfizer's Ascent Signals Broader Health Sector Resilience Amidst Innovation Wave
Via MarketMinute
Topics Artificial Intelligence Economy Intellectual Property

Frequently Asked Questions

Is Johnson & Johnson publicly traded?
Yes, Johnson & Johnson is publicly traded.
What exchange does Johnson & Johnson trade on?
Johnson & Johnson trades on the New York Stock Exchange
What is the ticker symbol for Johnson & Johnson?
The ticker symbol for Johnson & Johnson is JNJ on the New York Stock Exchange
What is the current price of Johnson & Johnson?
The current price of Johnson & Johnson is 174.53
When was Johnson & Johnson last traded?
The last trade of Johnson & Johnson was at 08/14/25 11:41 AM ET
What is the market capitalization of Johnson & Johnson?
The market capitalization of Johnson & Johnson is 458.78B
How many shares of Johnson & Johnson are outstanding?
Johnson & Johnson has 459B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.